eNOS gene affects red cell deformability: Role of T-786C, G894T, and 4a/4b polymorphisms

Clinical and Applied Thrombosis/Hemostasis

Volumn 11, Issue 4, 2005, Pages 481-488

  Fatini, Cinzia ^a,c   Mannini, Lucia ^a   Sticchi, Elena ^a   Cecchi, Emanuele ^a   Bruschettini, Alessia ^a   Leprini, Emanuela ^b   Pagnini, Paolo ^b   Gensini, Gian Franco ^a   Prisco, Domenico ^a   Abbate, Rosanna ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Centro Trombosi   (Italy)

Author keywords

4a 4b polymorphisms; Blood viscosity; eNOS T 786C; G894T; Haemorheologic state; Red cell deformability

Indexed keywords

CYTOSINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANINE; NITRIC OXIDE; THYMINE;

ADULT; AGED; ALLELE; ARTICLE; BIOAVAILABILITY; BLOOD RHEOLOGY; CONTROLLED STUDY; DOMINANT INHERITANCE; ENOS GENE; ERYTHROCYTE DEFORMABILITY; FEMALE; GENE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; MICROCIRCULATORY DISORDER; PERCEPTION DEAFNESS; PLASMA VISCOSITY; PRIORITY JOURNAL; RISK FACTOR; VASODILATATION;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTES; FEMALE; GENOTYPE; GLYCINE; HEARING LOSS, SENSORINEURAL; HEMORHEOLOGY; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; TYROSINE;

EID: 27544440123     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960501100417     Document Type: Article

References (36)

1. Klingel R, Fassbender C, Fassbender T, et al. Rheopheresis: Rheologic, functional, and structural aspects. Ther Apher 2000;4:348.
2. Pohl U, Holtz J, Busse R, et al. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 1986;8:37.
3. Cooke JP, Rossitch E Jr, Andon NA, et al. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest 1991;88:1663.
4. Rees DD, Palmer RM, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci 1989;86:3375.
5. Huang PL, Huang Z, Mashimo H, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995;377:239.
6. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002.
7. Lefer AM. Nitric oxide: Nature's naturally occurring leukocyte inhibitor. Circulation 1997;95:553.
8. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;2:1057.
9. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774.
10. Loscalzo J, Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis 1995;38:87.
11. Korbut R, Gryglewski RJ. Nitric oxide from polymorphonuclear leukocytes modulates red blood cell deformability in vitro. Eur J Pharmacol 1993;234:17.
12. Starzyk D, Korbut R, Gryglewski RJ. The role of nitric oxide in regulation of deformability of red blood cells in acute phase of endotoxaemia in rats. J Physiol Pharmacol 1997;48:731.
13. Bor-Kucukatay M, Wenby RB, Meiselman HJ, et al. Effects of nitric oxide on red blood cell deformability. Am J Physiol Heart Circ Physiol 2003;284:H1577.
14. Bateman RM, Jagger JE, Sharpe MD, et al. Erytrocyte deformability is a nitric oxide-mediated factor in decreased capillary density during sepsis. Am J Physiol Heart Circ Physiol 2001;280:H2848.
15. Ciuffetti G, Scardazza A, Serafini G, et al. Whole-blood filterability in sudden deafness. Laryngoscope 1991;101:65.
16. Mannini L, Paniccia R, Cecchi E, et al. Haemorheological and haemostatic alterations in patients with idiopathic sudden sensorineural hearing loss. Presented at the 18th International Congress on Thrombosis, Ljubljana, 2004.
17. Sticchi E, Fatini C, Gensini F, et al. High-speed detection of the G894T polymorphism in exon 7 of the eNOS gene by real-time fluorescence PCR with the light-cycler. Biochem Genet 2004;42:121.
18. International Committee for Standardization in Haematology. Guidelines for measurement of blood viscosity and erythrocyte deformability. Clin Hemorheol 1986;6:439.
19. Magyar MT, Szikszai Z, Balla J, et al. Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers. Stroke 2003;34:58.
20. Ramakrishnan S, Grebe R, Singh M, et al. Influence of local anaesthetics on the aggregation and deformability of erythrocytes. Clin Hemorheol Microcirc 1999;20:21.
21. Gatehouse S, Gallacher JEJ, Lowe GDO, et al. Blood viscosity and hearing levels in the Caerphilly Collaborative Heart Disease Study. Arch Otolaryngol Head Neck Surg 1989;115:1227.
22. Ohinata Y, Makimoto K, Kawakami M, et al. Blood viscosity and plasma viscosity in patients with sudden deafness. Acta Otolaryngol 1994;114:601.
23. Traub O, Berk BC. Laminar shear stress-Mechanisms by which endothelial cells tranduce an atheroprotective force. Atheroscler Thromb Vasc Biol 1998;18:677.
24. Nakayama T, Yasue H, Yoshimura M, et al. T-786C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999;99:2864.
25. Hingorani AD. Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2001. Atherosclerosis 2000;154:521.
26. Fatini C, Sofi F, Sticchi E, et al. Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a/4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. Am Heart J 2004;147:516.
27. Fatini C, Sofi F, Gensini F, et al. Influence of eNOS gene polymorphisms on carotid atherosclerosis. Eur J Vasc Endovasc Surg 2004;27:540.
28. Fatini C, Gensini F, Sticchi E, et al. High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. Am J Med 2002;112:540.
29. Korbut R, Gryglewski RJ. The effect of prostacyclin and nitric oxide on deformability of red blood cells in septic shock in rats. J Physiol Pharmacol 1996;47:591.
30. 2+ influx and cAMP-mediated signalling pathways. Am J Physiol Cell Physiol 1997;273:01828.
31. Mohandas N, Chasis JA, Shohet SB. The influence of membrane skeleton on red cell deformability, membrane material properties, and shape. Sem Hematol 1983;20:225.
32. Shiga T, Maeda N, Kon K. Erytrocyte rheology. Crit Rev Oncol Hematol 1990;10:9.
33. + exchange by soluble and paniculate guanylate cyclase. Am J Physiol Cell Physiol 1996;271:C1556.
34. +-ATPase activity through cyclic GMP pathway in proximal rat trachea. Eur J Pharmacol 1999;367:307.
35. 2+ uptake into platelet membrane vesicles. Biochem Biophys Res Commun 1996;222:780.
36. Smulders RA, Aarsen M, Teerlink T, et al. Haemodynamic and biochemical responses to L-arginine and lysine infusions in normal subjects: L-arginine-induced vasodilatation cannot be explained by non-specific effects of cationic amino acids. Clin Sci 1997;92:367.